Recent advances in mucosal immunology have provoked recent interest in the application of biodrugs to Crohn’s disease intestinal inflammation. Our un
Mydock-McGrane LK, Hannan TJ, Janetka JW (2017) Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease. Expert Opin Drug Dis 12: 711-731.Mydock-McGrane, L.K.; Hannan, T.J.; Janetka, J.W. Rational design strategies ...
Despite dramatic advances in our understanding of the pathogenesis and course of disease in the relatively short timeframe since the discovery and first de
for johne's disease in ruminants and it is possibly linked to crohn's disease in humans. m. bovis causes tuberculosis in most animals and in cattle in particular. m. tuberculosis and m. leprae cause tuberculosis and leprosy in humans, respectively. a list of the 60 most dissimilar functions...
Crohn's disease in humans.M. boviscauses tuberculosis in most animals and in cattle in particular.M. tuberculosisandM. lepraecause tuberculosis and leprosy in humans, respectively. A list of the 60 most dissimilar functions according tosimRelis given in the Supplement (seeAdditional file 1, ...
Crohn’s disease (CD) leads to a poor health-related quality of life (HRQoL). This review aimed to investigate the effect of biological agents and small-molecule drugs in improving the HRQoL of patients with moderate to severe CD. We adopted a systematic
and susceptibility to antiviral drugs, vaccines, and the host immune response. The best strategy to face the emergence of new infectious genomes is prompt identification. However, currently available diagnostic tests are often limited for detecting new agents. High-throughput next-generation sequencing ...
A disease of thecolon orrectum, such asulcerative colitisor Crohn’s disease Note: In place of colonoscopy or home stool tests, some people might consider two other visual exams of their colon and rectum, typically recommended every 5 years: ...
Combining the two drug-delivery platforms, that is, 3D printing and SNEDDSs, would further aid in developing new strategies for developing poorly soluble drugs while overcoming the above-mentioned challenges, and open new avenues for personalized drug delivery with added therapeutic benefits. The FDM...